|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2006-4-10
|
|
pubmed:abstractText |
The prognosis of a patient with estrogen receptor (ER) and/or progesterone receptor (PR) -positive breast cancer can be highly variable. Therefore, we developed a gene expression-based outcome predictor for ER+ and/or PR+ (ie, luminal) breast cancer patients using biologic differences among these tumors.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1656-64
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16505416-Breast Neoplasms,
pubmed-meshheading:16505416-Cell Line, Tumor,
pubmed-meshheading:16505416-Humans,
pubmed-meshheading:16505416-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:16505416-Prognosis,
pubmed-meshheading:16505416-Proportional Hazards Models,
pubmed-meshheading:16505416-Receptors, Estrogen,
pubmed-meshheading:16505416-Receptors, Progesterone
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.
|
|
pubmed:affiliation |
Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
